Prospective analysis of antibiotic susceptibility patterns of MRSA in a Turkish University Hospital

Turkish Journal of Medical Sciences

Volumn 35, Issue 5, 2005, Pages 323-327

  Savaş, Lütfü ^a   Duran, Nizami ^a   Önlen, Yusuf ^a   Savaş, Nazan ^a   Erayman, Mustafa ^a  

^a MUSTAFA KEMAL UNIVERSITY   (Turkey)

Author keywords

Antibiotic; MRSA; Resistance; Staphylococcus aureus; Susceptibility

Indexed keywords

DISEASES; HOSPITALS; MEDICAL APPLICATIONS; MEDICINE; PATIENT TREATMENT;

MRSA; STAPHYLOCOCCUS AUREUS; SUSCEPTIBILITY;

ANTIBIOTICS;

ANTIBIOTIC AGENT; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; NORFLOXACIN; OFLOXACIN; OXACILLIN; PENICILLIN G; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BURN UNIT; COAGULASE POSITIVE STAPHYLOCOCCUS; CONTROLLED STUDY; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; TURKEY (REPUBLIC); UNIVERSITY HOSPITAL;

EID: 32544433315     PISSN: 13000144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Jevons MP. Celbenin-resistant staphylococci. Br Med J 1: 124-5, 1961.
2. Ricbet HM, Mohammed J, McDonald LC et al. INSPEAR. Building communication networks: International network for the study and prevention of emerging antimicrobial resistance. Emerging Infectious Diseases 7: 319-22, 2001.
3. Ayliffe GAJ. The progressive intercontinental spread of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 1: 74-9, 1997.
4. Voss A, Doebbeling BN. The worldwide prevalence of methicillin-resistant Staphylococcus aureus. Int J Antimicrob Agents 5: 101-6, 1995.
5. Stefani S, Varaldo PE. Epidemiology of methicillin-resistant staphylococci in Europe. Clin Microbiol Infect 9: 1179-86, 2003.
6. Kloos WE, Schleifer KH. Staphylococcus. In P. H. A. Sneath et al. (ed.), Bergey's manual of systematic bacteriology, Vol. 2. The Williams and Wilkins Co., Baltimore, MD. 1986: 1013-9.
7. Aribas ET, Ozcan M, Altindis M. The antibiotics resistance rates of Staphylococci isolated from various clinical specimens. Infek Derg 15: 73-7, 2001.
8. Unlu G, Unlu M. Aminoglycosides susceptibility of Staphylococcus aureus strains isolated from wound specimens. Infek Derg 15: 239-42, 2001.
9. Somer A, Yalçin I, Ongen B et al. The resistance rate of Staphylococcus aureus strains to various antibiotics isolated from department of pediatrics infectious diseases. Infek Derg; 4: 369-72, 2001.
10. Leclercq R. Staphylococci resistant to antibiotic therapy. Ann Fr Anesth Reanim 21: 375-83, 2002.
11. Santos SI, Mato R, de Lencastre H et al. CEM/NET Collaborators and the International Collaborators. Patterns of multidrug resistance among methicillin-resistant hospital isolates of coagulase-positive and coagulase-negative staphylococci collected in the international multicenter study RESIST in 1997 and 1998. Microb Drug Resist 6: 199-211, 2000.
12. Degerli K, Ozbakkaloglu B, Surucuoglu S et al. The susceptibility rates of Staphylococcus aureus strains to various antibiotics isolated from clinical specimens. Infek Derg 14: 87-90, 2000.
13. Gastmeier P, Sohr D, Geffers C et al. Occurrence of methicillin-resistant Staphylococcus aureus infections in German intensive care units. Infection 30: 198-202, 2002.
14. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disc susceptibility tests. Approved standard. M2-A6. NCCLS, 6th ed. Wayne, PA: 1997.
15. Braun R, Hassler D. Methicillin-resistant Staphylococcus aureus (MRSA) infections spread in USA. Dtsch Med Wochenschr 28: 855, 2003.
16. Torregrossa MV, Cannova L, Sucameli M et al. Dispersal of methicillin resistant Staphylococcus aureus (MRSA) in a burn intensive care unit. Ann Ig 15: 107-10, 2003.
17. Chambers HF. The changing epidemiology of Staphylococcus aureus? Emerg Infect Dis 7: 178-82, 2001.
18. Boyce JM. Are the epidemiology and microbiology of methicillin-resistant Staphylococcus aureus changing? JAMA 279: 623-4, 1998.
19. Szewczyk EM, Piotrowski A, Rozalska M. Predominant staphylococci in the intensive care unit of a paediatric hospital. J Hosp Infect 45: 145-54, 2000.
20. Goldrick B. First reported case of VRSA in the United States. Am J Nurs 102: 17, 2002.
21. CDC. Interim guidelines for prevention and control of staphylococcal infection associated with reduced susceptibility to vancomycin. MMWR Morb Mortal Wkly Rep 46: 626-35, 1997.
22. Hwang SH, Kim MN, Pai CH et al. In vitro activities of quinupristin/dalfopristin and eight other antimicrobial agents against 360 clinical isolates from Korea. Yonsei Med J 41: 563-9, 2000.
23. Mutnick AH, Biedenbach DJ, Turnigge JD et al. Spectrum and potency evaluation of a new oxazolidinone, linezolid: Report from the SENTRY Antimicrobial Surveillance Program, 1998-2000. Diagn Microbiol Infect Dis 43: 65-73, 2002.
24. Basetti M, Melica G, Cenderello G et al. Gram positive bacterial resistance. A challenge for the next millenium. Panminerva Med 44: 179-84, 2002.